Researchers sought to analyze how pain management affects quality of life and overall survival for patients with recurrent ovarian cancer.
Younger patients with colorectal cancer are more likely to present with abdominal pain and via an emergency.
Two separate oral rinses were found to reduce pain from oral mucositis and mouth sores in patients receiving radiation therapy for head and neck cancers when compared to placebo.
Children with cancer who were asked to choose the type of medical support received during invasive procedures were found to be empowered and to experience reduced levels of distress.
Articles discussing the use of cannabis as a substitute for opioids highlight the limitations of the existing scientific evidence in the field.
An artificial intelligence (AI)-based smartphone app can reduce the severity of cancer patients’ reported pain and hospital admissions.
Artificial intelligence and mobile technology combined in a smartphone app demonstrated an ability to accurately measure and respond to urgency of patients’ pain.
Pain Management Index scores were found to be inversely associated with the percentage of patients who experience pain interference.
Two single nucleotide polymorphisms in the gene encoding for TAO kinase 3 were found to be associated with higher opioid dose requirements in patients with cancer pain.
The majority of patients with cancer who are being treated with World Health Organization Step III opioids were found to experience poor sleep quality, often due to pain.